Cancer Health Treatment Update Task Force Recommends Colon Cancer Screening at Age 45 The starting age was lowered due to an increase in colorectal cancer among younger people. Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age Researchers are developing a new class of drugs that deliver radiation therapy directly to cancer cells. What's in the Pipeline for NAFLD and NASH Treatment? Development of therapies for fatty liver disease—which can lead to cirrhosis and liver cancer—has proved challenging. New Report Adds Up the Financial Burden of a Cancer Diagnosis The report found U.S. cancer patients spent $5.6 billion in out-of-pocket costs for cancer treatment in 2018.  News From the ESMO Virtual Congress See all our reports from Europe's biggest cancer conference. FDA Approves Remdesivir for Hospitalized COVID-19 Patients The antiviral drug is the first treatment for the new coronavirus to be approved in the United States. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For other news about the new coronavirus, visit COVID Health. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed Task Force Recommends Colon Cancer Screening at Age 45 Could Dietary Supplements Boost Breast Cancer Risk? New Report Adds Up the Financial Burden of a Cancer Diagnosis Latinos Working in Food Processing and Agriculture Face Greater COVID-19 Risk Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma Newsfeed Task Force Recommends Colon Cancer Screening at Age 45 Could Dietary Supplements Boost Breast Cancer Risk? New Report Adds Up the Financial Burden of a Cancer Diagnosis Latinos Working in Food Processing and Agriculture Face Greater COVID-19 Risk Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: